Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues

Archives of Physiology and Biochemistry

Volumn 117, Issue 3, 2011, Pages 131-139

  Cohen, G ^a   Riahi, Y ^a   Sasson, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

4 hydroxydodecadienal; 4 hydroxynonenal; Adipose tissue; diabetes; inflammation; lipid peroxidation; lipoxygenase; obesity; PLA2

Indexed keywords

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; ALDEHYDE; CROSS LINKING REAGENT; LIPOXYGENASE; UNSATURATED FATTY ACID;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFERENCE PAPER; HUMAN; INFLAMMATION; LIPID PEROXIDATION; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ALDEHYDES; ANIMALS; CROSS-LINKING REAGENTS; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; LIPID PEROXIDATION; LIPOXYGENASES; MOLECULAR STRUCTURE; OBESITY;

EID: 79959214007     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.557387     Document Type: Conference Paper

References (95)

1. Ando K, Fujita T. (2009). Metabolic syndrome and oxidative stress. Free Radic Biol Med 47:213-18.
2. Awasthi YC, Yang Y, Tiwari NK, Patrick B, Sharma A, Li J, Awasthi S. (2004). Regulation of 4-hydroxynonenal-mediated signaling by glutathione s-transferases. Free Radic Biol Med 37:607-19. (Pubitemid 38993509)
3. Bacot S, Bernoud-Hubac N, Baddas N, Chantegrel B, Deshayes C, Doutheau A, Lagarde M, Guichardant M. (2003). Covalent binding of hydroxy-alkenals 4-hdde, 4-hhe, and 4-hne to ethanolamine phospholipid subclasses. J Lipid Res 44:917-26. (Pubitemid 37279652)
4. Bacot S, Bernoud-Hubac N, Chantegrel B, Deshayes C, Doutheau A, Ponsin G, Lagarde M, Guichardant M. (2007). Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. J Lipid Res 48:816-25. (Pubitemid 46557886)
5. Belkner J, Chaitidis P, Stender H, Gerth C, Kuban RJ, Yoshimoto T, Kuhn H. (2005). Expression of 12/15-lipoxygenase attenuates intracellular lipid deposition during in vitro foam cell formation. Arterioscler Tromb Vasc Biol 25:797-802. (Pubitemid 40463872)
6. Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. (2006). C-jun n-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 41:443-54. (Pubitemid 44037279)
7. Bourlier V Bouloumie A. (2009). Role of macrophage tissue infltration in obesity and insulin resistance. Diabetes Metab 35:251-60.
8. Bruce KD, Byrne CD. (2009). Te metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 85:614-21.
9. Buczynski MW, Dumlao DS, Dennis EA. (2009). Tematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015-38.
10. Bui PH, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. (2011). Human cytochrome p450, cyp2s1, metabolizes cyclooxygenase-and lipoxygenase-derived eicosanoids. Drug Metab Dispos 39:180-190.
11. Burke JE, Dennis EA. (2009). Phospholipase a2 structure/function, mechanism, and signaling. J Lipid Res 50 Suppl:S237-42.
12. Canuto RA, Ferro M, Muzio G, Bassi AM, Leonarduzzi G, Maggiora M, Adamo D, Poli G, Lindahl R. (1994). Role of aldehyde metabolizing enzymes in mediating efects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 15:1359-64. (Pubitemid 24217687)
13. Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL. (2009). 12/15-lipoxygenase products induce infammation and impair insulin signaling in 3t3-l1 adipocytes. Obesity (Silver Spring) 17:1657-63.
14. Chakrabarti SK, Wen Y, Dobrian AD, Cole BK, Ma Q, Pei H, Williams MD, Bevard MH, Vandenhof GE, Keller SR, Gu J, Nadler JL. (2011). Evidence for activation of infammatory lipoxygenase pathways in visceral adipose tissue of obese zucker rats. Am J Physiol Endocrinol Metab 300:E175-E187.
15. Chen ZH, Niki E. (2006). 4-hydroxynonenal (4-hne) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-hne also exert protective efects? IUBMB Life 58:372-3. (Pubitemid 43880031)
16. Coleman JD, Prabhu KS, Tompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, Vanden Heuvel JP. (2007). Te oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (pparbeta/delta). Free Radic Biol Med 42:1155-64. (Pubitemid 46428510)
17. Demozay D, Mas JC, Rocchi S, Van Obberghen E. (2008). Faldh reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3t3-l1 adipocytes. Diabetes 57:1216-26.
18. Devaraj S, Wang-Polagruto J, Polagruto J, Keen CL, Jialal I. (2008). High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57:867-70. (Pubitemid 351697920)
19. Dianzani MU. (2003). 4-hydroxynonenal from pathology to physiology. Mol Aspects Med 24:263-72.
20. Duncan RE, Sarkadi-Nagy E, Jaworski K, Ahmadian M, Sul HS. (2008). Identification and functional characterization of adipose-specific phospholipase a2 (adpla). J Biol Chem 283:25428-36.
21. Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. (2007). Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 12:4-10. (Pubitemid 46210346)
22. Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ et al. (2003). A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22:4103-10. (Pubitemid 37021739)
23. Eckardt K, Sell H, Eckel J. (2008). Novel aspects of adipocyte-induced skeletal muscle insulin resistance. Arch Physiol Biochem 114:287-98.
24. Engle MR, Singh SP, Czernik PJ, Gaddy D, Montague DC, Ceci JD, Yang Y Awasthi S, Awasthi YC, Zimniak P. (2004). Physiological role of mgsta4-4, a glutathione s-transferase metabolizing 4-hydroxynonenal: Generation and analysis of mgsta4 null mouse. Toxicol Appl Pharmacol 194:296-308. (Pubitemid 38180461)
25. Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128. (Pubitemid 121003917)
26. Esteve E, Ricart W, Fernandez-Real JM. (2009). Adipocytokines and insulin resistance: Te possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 32 Suppl 2:S362-7.
27. Furstenberger G, Epp N, Eckl KM, Hennies HC, Jorgensen C, Hallenborg P, Kristiansen K, Krieg P. (2007). Role of epidermis-type lipoxygenases for skin barrier function and adipocyte diferentiation. Prostaglandins Other Lipid Mediat 82:128-34. (Pubitemid 44880166)
28. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. (2010). Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: Role of atgl, hsl, and ampk. Am J Physiol Cell Physiol 298:C961-71
29. Galic S, Oakhill JS, Steinberg GR. (2010). Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129-39.
30. Gardner HW, Hamberg M. (1993). Oxygenation of (3z)-nonenal to (2e)-4-hydroxy-2-nonenal in the broad bean (vicia faba l.). J Biol Chem 268:6971-7. (Pubitemid 23105580)
31. Grimsrud PA, Picklo MJ, Sr., Grifn TJ, Bernlohr DA. (2007). Carbonylation of adipose proteins in obesity and insulin resistance: Identifcation of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 6:624-37. (Pubitemid 46630095)
32. Grune T, Davies KJ. (2003). Te proteasomal system and hne-modifed proteins. Mol Aspects Med 24:195-204.
33. Gueraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L, Jouanin I, Siems W, Uchida K. (2010). Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44:1098-124.
34. Guichardant M, Bacot S, Moliere P, Lagarde M. (2006). Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids 75:179-82. (Pubitemid 44308583)
35. Guichardant M, Chantegrel B, Deshayes C, Doutheau A, Moliere P, Lagarde M. (2004). Specifc markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans 32:139-40. (Pubitemid 38283034)
36. Guilherme A, Virbasius JV, Puri V, Czech MP. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-77. (Pubitemid 351574198)
37. Guzik TJ, Mangalat D, Korbut R. (2006). Adipocytokines-novel link between infammation and vascular function? J Physiol Pharmacol 57:505-28. (Pubitemid 46096102)
38. Hallenborg P, Jorgensen C, Petersen RK, Feddersen S, Araujo P, Markt P, Langer T, Furstenberger G, Krieg P, Koppen A, et al (2010). Epidermis-type lipoxygenase 3 regulates adipocyte diferentiation and peroxisome proliferator-activated receptor gamma activity. Mol Cell Biol 30:4077-91.
39. Hotamisligil GS. (2006). Infammation and metabolic disorders. Nature 444:860-7.
40. Huo Y Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, et al. (2004). Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein e-defcient mice. Circulation 110:2024-31. (Pubitemid 39331917)
41. Ii H, Hatakeyama S, Tsutsumi K, Sato T, Akiba S. (2008). Group iva phospholipase a2 is associated with the storage of lipids in adipose tissue and liver. Prostaglandins Other Lipid Mediat 86:12-7.
42. Jaworski K, Ahmadian M, Duncan RE, Sarkadi-Nagy E, Varady KA, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, Kim KH, et al. (2009). Adpla ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin defciency. Nat Med 15:159-68.
43. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. (2009). Mechanisms of obesity and related pathology: Linking immune responses to metabolic stress. FEBS J 276:5747-54.
44. Kawajiri H, Zhuang D, Qiao N, Yoshimoto T, Yamamoto M, Iseki S, Hamaguchi K. (2000). Expression of arachidonate 12-lipoxygenase in rat tissues: A possible role in glucagon secretion. J Histochem Cytochem 48:1411-9.
45. Keaney Jr JF, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. (2003). Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the framingham study. Arterioscler Tromb Vasc Biol 23:434-9. (Pubitemid 36337219)
46. Lamers D, Schlich R, Greulich S, Sasson S, Sell H, Eckel J. (2011). Oleic acid and adipokines synergize in inducing proliferation and infammatory signaling in human vascular smooth muscle cells. J Cell Mol Med, Epub ahead of print.
47. Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G. (2000). Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370-8. (Pubitemid 30621481)
48. Long SD, Pekala PH. (1996). Regulation of glut4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin e2. J Biol Chem 271:1138-44.
49. Madsen L, Petersen RK, Sorensen MB, Jorgensen C, Hallenborg P, Pridal L, Fleckner J, Amri EZ, Krieg P, Furstenberger G, et al. (2003). Adipocyte diferentiation of 3t3-l1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the diferentiation process. Biochem J 375:539-49. (Pubitemid 37433502)
50. Martinez JA. (2006). Mitochondrial oxidative stress and infammation: A slalom to obesity and insulin resistance. J Physiol Biochem 62:303-6. (Pubitemid 46938959)
51. Mattson MP. (2009). Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 44:625-33.
52. Niki E. (2009). Lipid peroxidation: Physiological levels and dual biological efects. Free Radic Biol Med 47:469-84.
53. Nugent C, Prins JB, Whitehead JP, Wentworth JM, Chatterjee VK, O'Rahilly S. (2001). Arachidonic acid stimulates glucose uptake in 3t3-l1 adipocytes by increasing glut1 and glut4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 276:9149-57.
54. Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD, Yang Z, Smith KM, Wu R, Bevard MH, et al. (2008). 12-lipoxygenase-knockout mice are resistant to infammatory efects of obesity induced by western diet. Am J Physiol Endocrinol Metab 295:E1065-75
55. Olefsky JM, Glass CK. (2010). Macrophages, infammation, and insulin resistance. Annu Rev Physiol 72:219-46.
56. Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M. (2007). Hne michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: Lc-ms/ms profling in zucker obese rats. Anal Chem 79:9174-84. (Pubitemid 350231731)
57. Park Y Pariza MW. (2001). Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3t3-l1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta 1534:27-33. (Pubitemid 34025110)
58. Petersen DR, Doorn JA. (2004). Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 37:937-45. (Pubitemid 39164576)
59. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. (2004). Oxidative stress and cell signalling. Curr Med Chem 11:1163-82. (Pubitemid 38585060)
60. Pryor WA, Porter NA. (1990). Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic Biol Med 8:541-3. (Pubitemid 20204418)
61. Rasouli N, Kern PA. (2008). Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-73
62. Riahi Y, Cohen G, Shamni O, Sasson S. (2010a). Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol Endocrinol Metab 299:E879-86
63. Riahi Y Sin-Malia Y, Cohen G, Alpert E, Gruzman A, Eckel J, Staels B, Guichardant M, Sasson S. (2010b). Te natural protective mechanism against hyperglycemia in vascular endothelial cells: Roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta. Diabetes 59:808-18.
64. Ronti T, Lupattelli G, Mannarino E. (2006). Te endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64:355-65.
65. Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Deriaz O, Golay A, Witztum JL, Giacobino JP. (2003). Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: A case of good vs. Bad lipids? FEBS Lett 551:104-6. (Pubitemid 37281335)
66. Schaloske RH, Dennis EA. (2006). Te phospholipase a2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246-59. (Pubitemid 44755364)
67. Schaur RJ. (2003). Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24:149-59. (Pubitemid 36945015)
68. Schneider C. (2009). An update on products and mechanisms of lipid peroxidation. Mol Nutr Food Res 53:315-21.
69. Schneider C, Porter NA, Brash AR. (2008). Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 283:15539-43.
70. Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Tapar D, Miller YI. (2009). 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue infammation and insulin resistance in mice. PLoS One 4:e7250.
71. Sell H, Eckel J. (2009). Chemotactic cytokines, obesity and type 2 diabetes: In vivo and in vitro evidence for a possible causal correlation? Proc Nutr Soc 68:378-84.
72. Sell H, Eckel J. (2010). Adipose tissue infammation: Novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 13:366-70.
73. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. (2009). Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58:2731-40.
74. Shillabeer G, Kumar V, Tibbo E, Lau DC (1998). Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte diferentiation. Metabolism 47:461-6. (Pubitemid 28180954)
75. Shireman LM, Kripps KA, Balogh LM, Conner KP, Whittington D, Atkins WM. (2010). Glutathione transferase a4-4 resists adduction by 4-hydroxynonenal. Arch Biochem Biophys 504:182-9.
76. Singh SP, Niemczyk M, Saini D, Awasthi YC, Zimniak L, Zimniak P. (2008). Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 47:3900-11. (Pubitemid 351431379)
77. Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaidi-Tiali N, Lagarde M, Geloen A. (2005). Efects of oxidative stress on adiponectin secretion and lactate production in 3t3-l1 adipocytes. Free Radic Biol Med 38:882-9. (Pubitemid 40321080)
78. Srivastava S, Chandra A, Wang LF, Seifert WE, Jr., DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A. (1998). Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 273:10893-900. (Pubitemid 28204926)
79. Tam CS, Clement K, Baur LA, Tordjman J. (2010). Obesity and low-grade infammation: a paediatric perspective. Obes Rev 11:118-26.
80. Taube A, Eckardt K, Eckel J. (2009). Role of lipid-derived mediators in skeletal muscle insulin resistance. Am J Physiol Endocrinol Metab, 287:E1004-E1012.
81. Tebbey PW, McGowan KM, Stephens JM, Buttke TM, Pekala PH. (1994). Arachidonic acid down-regulates the insulin-dependent glucose transporter gene (glut4) in 3t3-l1 adipocytes by inhibiting transcription and enhancing mrna turnover. J Biol Chem 269:639-44. (Pubitemid 24026707)
82. Tejero I, Gonzalez-Lafont A, Lluch JM, Eriksson LA. (2007). Teoretical modeling of hydroxyl-radical-induced lipid peroxidation reactions. J Phys Chem B 111:5684-93. (Pubitemid 46910829)
83. Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, Tanaka T, Hiai H, Seino Y Uchida K. (2000). Serum 4-hydroxy-2-nonenal-modifed albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal 2:681-5. (Pubitemid 32062319)
84. Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari UM. (2002). Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med 32:350-9. (Pubitemid 34159089)
85. Uchida K. (2003). 4-hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res 42:318-43. (Pubitemid 36411689)
86. Uchida Y, Ohba K, Yoshioka T, Irie K, Muraki T, Maru Y. (2004). Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway. J Biol Chem 279:4075-83. (Pubitemid 38198991)
87. Vincent HK, Powers SK, Dirks AJ, Scarpace PJ. (2001). Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int J Obes Relat Metab Disord 25:378-88. (Pubitemid 32209814)
88. Wen Y Gu J, Vandenhof GE, Liu X, Nadler JL. (2008). Role of 12/15-lipoxygenase in the expression of mcp-1 in mouse macrophages. Am J Physiol Heart Circ Physiol 294:H1933-8 (Pubitemid 351490623)
89. Wolf G. (2009). Adipose-specifc phospholipase as regulator of adiposity. Nutr Rev 67:551-4.
90. Xiao WJ, He JW, Zhang H, Hu WW, Gu JM, Yue H, Gao G, Yu JB, Wang C, Ke YH, et al. (2010). Alox12 polymorphisms are associated with fat mass but not peak bone mineral density in chinese nuclear families. Int J Obes (Lond), Epub ahead of print.
91. Yan J, Hales BF. (2006). Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo. J Pharmacol Exp Ter 319:613-21.
92. Yang Y Xu Y Lick SD, Awasthi YC, Boor PJ. (2008). Endothelial glutathione-s-transferase a4-4 protects against oxidative stress and modulates inos expression through nf-kappab translocation. Toxicol Appl Pharmacol 230:187-96.
93. Yoshimoto T, Takahashi Y. (2002). Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat, 68-69:245-62. (Pubitemid 35247400)
94. Zarkovic N. (2003). 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24:281-91. (Pubitemid 36945028)
95. Zarrouki B, Soares AF, Guichardant M, Lagarde M, Geloen A. (2007). Te lipid peroxidation end-product 4-hne induces cox-2 expression through p38mapk activation in 3t3-l1 adipose cell. FEBS Lett 581:2394-400. (Pubitemid 46764695)